1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate
(
- Contribution to journal › Article
- 2023
-
Mark
Co-administration with A1M does not influence apoptotic response of 177Lu-octreotate in GOT1 neuroendocrine tumors
(
- Contribution to journal › Article
-
Mark
Recombinant α
1-Microglobulin (rA1M) Protects against Hematopoietic and Renal Toxicity, Alone and in Combination with Amino Acids, in a
177Lu-DOTATATE Mouse Radiation Model.
(
- Contribution to journal › Article
- 2021
-
Mark
Effects of different mean arterial pressure targets on plasma volume, ANP and glycocalyx—A randomized trial
(
- Contribution to journal › Article
- 2019
-
Mark
Recombinant alpha-1-microglobulin is a potential kidney protector in 177Lu-octreotate treatment of neuroendocrine tumors
(
- Contribution to journal › Article
-
Mark
Protection of Kidney Function with Human Antioxidation Protein α
1
-Microglobulin in a Mouse
177
Lu-DOTATATE Radiation Therapy Model
(
- Contribution to journal › Article
- 2015
-
Mark
Potential Biomarkers for Radiation-Induced Renal Toxicity following 177Lu-Octreotate Administration in Mice.
(
- Contribution to journal › Article
- 2014
-
Mark
Evaluation of retinol binding protein 4 and carbamoylated haemoglobin as potential renal toxicity biomarkers in adult mice treated with Lu-177-octreotate
(
- Contribution to journal › Article
- 2002
-
Mark
Swedish Cancer Society radiation therapy research investigation.
(
- Contribution to journal › Article